Pfizer Unusual Options Activity
Pfizer Unusual Options Activity
Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer (NYSE:PFE) revealed 8 unusual trades.
金融巨頭們對輝瑞採取了明顯的看淡策略。我們對輝瑞（NYSE:PFE）期權歷史進行分析後發現8筆異常交易。
Delving into the details, we found 37% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $117,000, and 6 were calls, valued at $244,926.
深入研究後，我們發現37%的交易者看漲，而50%的交易者看淡。在我們發現的所有交易中，有2個看跌期權，價值117,000美元，而有6個看漲期權，價值244,926美元。
Projected Price Targets
預計價格目標
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $30.0 for Pfizer during the past quarter.
分析這些合約的成交量和未平倉量，我們發現大戶在過去一個季度一直關注輝瑞股價從15.0美元到30.0美元的一個價格區間。
Volume & Open Interest Development
成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團（Alibaba Gr Hldgs）特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內，阿里巴巴集團（Alibaba Gr Hldgs）在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中，成交量和持倉量的波動情況。
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Pfizer's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale trades within a strike price range from $15.0 to $30.0 in the last 30 days.
在交易期權時，關注成交量和未平倉量是個不錯的策略。這些數據可以幫助您追蹤特定行權價下關於輝瑞期權的流動性和興趣。下面，我們可以分別觀察過去30天內輝瑞所有鯨魚交易的成交量和未平倉量的變化，其中行權價區間爲15.0美元到30.0美元。
Pfizer 30-Day Option Volume & Interest Snapshot
輝瑞30天期權成交量快照和未平倉合約
Biggest Options Spotted:
最大的期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | CALL | SWEEP | BULLISH | 10/04/24 | $4.15 | $4.05 | $4.15 | $26.00 | $83.0K | 301 | 0 |
| PFE | PUT | SWEEP | BULLISH | 01/15/27 | $6.9 | $4.4 | $4.4 | $30.00 | $66.0K | 20 | 0 |
| PFE | PUT | TRADE | BULLISH | 01/16/26 | $3.45 | $3.4 | $3.4 | $30.00 | $51.0K | 30.7K | 0 |
| PFE | CALL | SWEEP | BEARISH | 10/18/24 | $0.89 | $0.87 | $0.87 | $30.00 | $50.4K | 22.2K | 887 |
| PFE | CALL | SWEEP | NEUTRAL | 01/16/26 | $15.75 | $14.75 | $15.3 | $15.00 | $30.5K | 565 | 20 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 輝瑞 | 看漲 | SWEEP | 看好 | 10/04/24 | $4.15 | $4.05 | $4.15 | 26.00美元 | 83,000美元 | 301 | 0 |
| 輝瑞 | 看跌 | SWEEP | 看好 | 01/15/27 | $6.9 | $4.4 | $4.4 | $30.00 | $66.0K | 20 | 0 |
| 輝瑞 | 看跌 | 交易 | 看好 | 01/16/26 | $3.45 | $3.4 | $3.4 | $30.00 | $51.0K | 30.7千 | 0 |
| 輝瑞 | 看漲 | SWEEP | 看淡 | 10/18/24 | $0.89 | $0.87 | $0.87 | $30.00 | $50.4K | 22.2千 | 887 |
| 輝瑞 | 看漲 | SWEEP | 中立 | 01/16/26 | $15.75 | $14.75 | $15.3 | 15.00美元 | $30.5K | 565 | 20 |
About Pfizer
關於輝瑞
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
輝瑞是全球最大的製藥公司之一，年銷售額接近500億美元（不包括COVID-19產品銷售）。它歷史上銷售過許多種醫療保健產品和化學品，現在處方藥和疫苗佔據了銷售額的大部分。暢銷產品包括肺炎球菌疫苗Prevnar 13，癌症藥物Ibrance和心血管治療藥Eliquis。輝瑞在全球範圍內銷售這些產品，國際銷售佔總銷售額的近50%。其中，新興市場是主要貢獻者。
Pfizer's Current Market Status
輝瑞的當前市場狀況
- With a volume of 1,860,933, the price of PFE is down -0.25% at $30.0.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 42 days.
- 輝瑞的成交量爲1,860,933，股價下跌了-0.25%，爲30.0美元。
- RSI指標暗示該股票可能要超買了。
- 下次業績預計將於42天后發佈。
What The Experts Say On Pfizer
專家們對輝瑞的評價
In the last month, 3 experts released ratings on this stock with an average target price of $45.0.
在最近一個月中，有3位專家發佈了對該股票的評級，平均目標價爲45.0美元。
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $45.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $45.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $45.
- 康泰納菲公司的一位分析師將其評級下調爲超配，設定了45.0美元的目標價。
- 康泰納菲公司的一位分析師將其評級下調爲超配，設定了45.0美元的目標價。
- 一位謹慎的康泰納菲公司分析師將其評級下調爲超配，設定了45.0美元的目標價。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。